Details for Patent: 7,776,838
✉ Email this page to a colleague
Which drugs does patent 7,776,838 protect, and when does it expire?
Patent 7,776,838 protects VISTOGARD and is included in one NDA.
This patent has one hundred and seventy-five patent family members in twenty-one countries.
Summary for Patent: 7,776,838
| Title: | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| Abstract: | The subject invention discloses compounds, compositions and methods for treatment and prevention of toxicity due to chemotherapeutic agents and antiviral agents. Disclosed are acylated derivatives of non-methylated pyrimidine nucleosides. These compounds are capable of attenuating damage to the hematopoietic system in animals receiving antiviral or antineoplastic chemotherapy. |
| Inventor(s): | von Borstel; Reid W. (Potomac, MD), Bamat; Michael K. (Potomac, MD) |
| Assignee: | Wellstat Therapeutics Corporation (Gaithersburg, MD) |
| Application Number: | 08/460,186 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,776,838
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Btg Intl | VISTOGARD | uridine triacetate | GRANULE;ORAL | 208159-001 | Dec 11, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | EMERGENCY TREATMENT OF ADULT & PEDIATRIC PATIENTS FOLLOWING FLUOROURACIL OR CAPECITABINE OVERDOSE,OR WHO EXHIBIT EARLY-ONSET,SEVERE OR LIFE-THREATENING CARDIAC OR CNS TOXICITY OR UNUSUALLY SEVERE ADVERSE REACTIONS WITHIN 96 HOURS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
